StayWell to exhibit patient engagement technology solutions at HiMSS 2017

StayWell News Releases

News release

(For Immediate release)


StayWell to exhibit patient engagement technology solutions at HiMSS 2017

Demonstrations of new SMART on FHIR app for Krames CareEngageTM, on-demand video capabilities, and hospital marketing solutions to be featured at StayWell booth 3443


YARDLEY, PA (Feb. 17, 2017)StayWell will take visitors on a journey through its leading-edge consumer engagement and digital marketing technology solutions at the HiMSS 2017 conference, Feb. 19-23 in Orlando, FL.

StayWell will conduct product demonstrations that explore technology solutions built to help hospitals and health systems manage the health of populations, improve patient outcomes across the care continuum, and engage current and prospective patients with hospital and health system brands.

StayWell’s clinical interactive and mobile patient engagement solutions allow providers to more easily share information with patients, creating a more cohesive patient experience and increasing adherence to care plans. The EHR interoperability facilitated by StayWell solutions drives patient engagement and can improve patient safety and outcomes.

All visitors to the StayWell booth will receive a passport that will be stamped for each demonstration they attend at booth 3443. Passports will be entered for prize drawings.


Location:                   Booth 3443 in the Orange County Convention Center

Presentations:          Patient-Centered Security Architecture: The Key to Personal Health Information (11:30 a.m. Monday and 3:30 p.m. Tuesday)

Mobile-Driven Patient Engagement: Next-Generation Patient-Centered Disease Management (12 p.m. Monday and 1 p.m. Tuesday)

ILÚM and MedHelp (12:30 p.m. Monday, 11 a.m. Tuesday, and
2 p.m. Wednesday)

It’s Not About You: Using Patient Stories to Transform Health Care (2:30 p.m. Monday)

Interoperable Patient Education: Serving Patients Along the Care Continuum (3 p.m. Monday and 10 a.m. Wednesday)

Providing a Consistent Patient Experience With SMART on FHIR (3:30 p.m. Monday, 11:30 a.m. Tuesday and 2:30 p.m. Wednesday)

Beyond a Prescription: Enhancing Medication Info Online and On the Go (4:30 p.m. Monday, 10:30 a.m. Tuesday and 11:30 a.m. Wednesday)

                                    Improving Patient Engagement Through Storytelling (10 a.m. Tuesday)

Infobutton, Blue Button, and Open Notes, Oh My!: Driving Toward Patient Engagement (12 p.m. Tuesday, and 3 p.m. Wednesday)

First Comes Marriage, Then Comes Engagement: The Union of Content and Technology (2:30 p.m. Tuesday)

What’s an Explainer To Do? Explaining Complex Subjects With Consumable, Fun, and Compelling Videos (12 p.m. Wednesday)

What Do the New Provisions In the Affordable Care Act Mean to You? (1 p.m. Wednesday)

Interviews:                 To schedule a one-on-one media briefing with StayWell during
or before HiMSS, contact Barbara Tabor at (651) 230-9192.



About StayWell

StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, Pennsylvania, and also has major locations in Salt Lake City, Utah, and St. Paul, Minn. To learn more, visit


About Merck

For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit and connect with us on TwitterFacebookYouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (


Media contact

Barbara Tabor, APR / 651-230-9192 /